Reuters: Israel's Teva Pharmaceutical Industries forecast $2.30-$2.55 adjusted earnings per share in 2020, in line with expectations

Reuters: Federal prosecutors are investigating six pharma firms for potential criminal charges regarding the shipping of opioid painkillers that led to healthcare crisis

Firm announces R&D partnerships with Weizmann Institute, Tel Aviv University in brain and cancer therapies; move marks foray into 'merging of minds between academia and pharma'

Reuters: The head of the US House of Representative’s oversight panel has asked three drugmakers to hand in documents, accusing them of 'efforts to stonewall' probe

Reuters: Revenue declined 8% to $4.34 billion, due mainly to generic competition to its flagship multiple sclerosis drug Copaxone

Ex-managers and directors reach compromise relating to penalties levied on pharmaceutical firm in US and Israel to settle charges of bribery under their watch, Calcalist reports

Israeli drugmaker avoids admitting wrongdoing but will no longer promote addictive painkillers in state; money to be divided between lawyers, special state fund

Israeli-owned pharmaceuticals giant being battered on multiple fronts over role in opioid epidemic, price fixing allegations

Struggling pharmaceutical giant hits another roadblock as it fights off lawsuits related to drug epidemic

Struggling Israeli pharmaceutical giant fighting multiple lawsuits